SHS Public: Innovation for the Future of Generics

How will innovation create value with generics in the future? 

DOORS OPEN (5:30 P.M.):
PLEASE NOTE: THE EVENT WILL BE HELD IN GERMAN)

WELCOMING WORDS / START (6:00 P.M.):
Dr. Fabian Unteregger, Co-Initiator and Member of the Board, Swiss Healthcare Startups 

THE ROLE OF THE GENERICS INDUSTRY IN THE ECOSYSTEM OF TODAY AND TOMORROW
Prof. Dr. med. Stephan Vavricka, Co-Founder, Centre for Gastroenterology and Hepatology

STARTUP PITCH: AN EXAMPLE OF HOW INNOVATION CREATED VALUE WITH GENERICS
Andreas Heizmann, Co-Founder, Xatena

THE GENERICS INDUSTRY’S VIEW:
HOW WILL INNOVATION CREATE VALUE WITH GENERICS IN THE FUTURE? 
Andreas Bosshard, General Manager, Mepha Schweiz AG
Jan Tangermann, Country Head Switzerland, Sandoz Pharmaceuticals AG 
 

PANEL: SEARCHING FOR SOLUTIONS
Andreas Bosshard, General Manager, Mepha Schweiz AG
Andreas Heizmann, Co-Founder, Xatena
Dr. Andreas Schiesser, Projectmanager Pharma, curafutura
Dr. Evangelos Avramakis, Head Digital Ecosystems R&D, Swiss Re Institute
Jan Tangermann, Country Head Switzerland, Sandoz Pharmaceuticals AG
Marion Bützberger-Grimm, Responsible pharmacist, Spital Männedorf
​

APÉRO AND NETWORKING 

Registration is now closed. If you would like to join spontaneously, please send us an e-mail to info@swisshealthcarestartups.com until 01.00 p.m. on November 26.